Masimo (NASDAQ:MASI) Sees Large Volume Increase – Time to Buy?

Masimo Corporation (NASDAQ:MASI) shares saw an uptick in trading volume on Tuesday . 2,009,264 shares traded hands during trading, an increase of 24% from the previous session’s volume of 1,614,900 shares.The stock last traded at $175.5250 and had previously closed at $175.40.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research report on Monday, December 1st. BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Stifel Nicolaus set a $180.00 target price on Masimo in a report on Tuesday, February 17th. Piper Sandler cut Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a research report on Tuesday, February 17th. Finally, Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. One equities research analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Masimo has a consensus rating of “Hold” and a consensus price target of $181.17.

Masimo Price Performance

The firm has a market cap of $9.44 billion, a P/E ratio of -16.68, a price-to-earnings-growth ratio of 1.78 and a beta of 1.21. The stock’s 50-day moving average is $152.63 and its 200-day moving average is $146.14. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72.

Hedge Funds Weigh In On Masimo

Several large investors have recently added to or reduced their stakes in MASI. Global Retirement Partners LLC bought a new stake in shares of Masimo during the fourth quarter valued at approximately $27,000. Aster Capital Management DIFC Ltd acquired a new stake in Masimo during the fourth quarter worth $28,000. Los Angeles Capital Management LLC bought a new stake in Masimo in the 4th quarter valued at $31,000. MAI Capital Management raised its stake in shares of Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 129 shares in the last quarter. Finally, Rothschild Investment LLC lifted its holdings in shares of Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 259 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.